Viewing StudyNCT06491914



Ignite Creation Date: 2024-07-17 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06491914
Status: RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-07-01

Brief Title: A Single-Arm Study of Aflibercept 8 mg Dosed in Adult Participants With Neovascular Age-Related Macular Degeneration nAMD or Diabetic Macular Edema DME
Sponsor: Regeneron Pharmaceuticals
Organization: Regeneron Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-24
Start Date Type: ESTIMATED
Primary Completion Date: 2026-01-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-05-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-07-01
First Submit QC Date: None
Study First Post Date: 2024-07-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-20
Last Update Post Date: 2024-07-09
Last Update Post Date Type: ACTUAL